| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | Canada | 2 | |
| #3 | United States | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Japan | 1 | |
| #7 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Sugars | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hermansen Kjeld | 12 |
| #2 | Jeppesen Per Bendix | 7 |
| #3 | Gregersen Soren | 5 |
| #4 | Bendix-Jeppesen Per | 2 |
| #5 | Gregersen Soeren | 2 |
| #6 | Bendix Jeppesen Per | 2 |
| #7 | Gregersen Seren | 1 |
| #8 | Jeppesen Per | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2008031439A2 | Treatment of insulin resistance or diseases associated with insulin resistance with bicyclo [ 3.2. i ]octans such as steviol and isosteviol | |
| CA2398445A1 | A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |